Dr Nellie Delucia Wood, MD | |
22 Bramhall St, Portland, ME 04102-3175 | |
(207) 662-0111 | |
Not Available |
Full Name | Dr Nellie Delucia Wood |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 6 Years |
Location | 22 Bramhall St, Portland, Maine |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1619472867 | NPI | - | NPPES |
MD24810 | Other | ME | LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | MD24810 (Maine) | Secondary |
207R00000X | Internal Medicine | MD24810 (Maine) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Maine Medical Center | Portland, ME | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Maine Medical Partners | 9335043967 | 789 |
Mainehealth | 7517860588 | 2067 |
News Archive
The research, reported in the New England Journal of Medicine, looked at the effect of a 2008 change that cut payments to hospitals for treating infections that patients received while hospitalized.
What factors have an influence in making us like sport in the physical education classes we receive in school? According to a new investigation, physical education teaching staff must develop the responsibility, encourage social interaction and avoid making comparisons between the pupils.
Wearing a surgical mask is unlikely to protect healthy people from the novel coronavirus that originated in China, and influenza likely poses a much greater threat to Americans, according to José Cordero, professor of epidemiology and biostatistics in the University of Georgia's College of Public Health.
Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, or white blood cells. By exploiting this mechanism, researchers have been able to powerfully suppress tumor formation in lab testing and in animal models.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has submitted additional patent applications, covering its Cobalamin-mediated oral drug delivery technology formulations of many global top-100 injectable drugs, as a result of the growing interest surrounding the company's proprietary oral delivery technology.
› Verified 3 days ago
Entity Name | Maine Medical Partners |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467477349 PECOS PAC ID: 9335043967 Enrollment ID: O20031125000026 |
News Archive
The research, reported in the New England Journal of Medicine, looked at the effect of a 2008 change that cut payments to hospitals for treating infections that patients received while hospitalized.
What factors have an influence in making us like sport in the physical education classes we receive in school? According to a new investigation, physical education teaching staff must develop the responsibility, encourage social interaction and avoid making comparisons between the pupils.
Wearing a surgical mask is unlikely to protect healthy people from the novel coronavirus that originated in China, and influenza likely poses a much greater threat to Americans, according to José Cordero, professor of epidemiology and biostatistics in the University of Georgia's College of Public Health.
Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, or white blood cells. By exploiting this mechanism, researchers have been able to powerfully suppress tumor formation in lab testing and in animal models.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has submitted additional patent applications, covering its Cobalamin-mediated oral drug delivery technology formulations of many global top-100 injectable drugs, as a result of the growing interest surrounding the company's proprietary oral delivery technology.
› Verified 3 days ago
Entity Name | Maine Medical Partners |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598780447 PECOS PAC ID: 9335043967 Enrollment ID: O20040220000847 |
News Archive
The research, reported in the New England Journal of Medicine, looked at the effect of a 2008 change that cut payments to hospitals for treating infections that patients received while hospitalized.
What factors have an influence in making us like sport in the physical education classes we receive in school? According to a new investigation, physical education teaching staff must develop the responsibility, encourage social interaction and avoid making comparisons between the pupils.
Wearing a surgical mask is unlikely to protect healthy people from the novel coronavirus that originated in China, and influenza likely poses a much greater threat to Americans, according to José Cordero, professor of epidemiology and biostatistics in the University of Georgia's College of Public Health.
Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, or white blood cells. By exploiting this mechanism, researchers have been able to powerfully suppress tumor formation in lab testing and in animal models.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has submitted additional patent applications, covering its Cobalamin-mediated oral drug delivery technology formulations of many global top-100 injectable drugs, as a result of the growing interest surrounding the company's proprietary oral delivery technology.
› Verified 3 days ago
Entity Name | Mainehealth |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
The research, reported in the New England Journal of Medicine, looked at the effect of a 2008 change that cut payments to hospitals for treating infections that patients received while hospitalized.
What factors have an influence in making us like sport in the physical education classes we receive in school? According to a new investigation, physical education teaching staff must develop the responsibility, encourage social interaction and avoid making comparisons between the pupils.
Wearing a surgical mask is unlikely to protect healthy people from the novel coronavirus that originated in China, and influenza likely poses a much greater threat to Americans, according to José Cordero, professor of epidemiology and biostatistics in the University of Georgia's College of Public Health.
Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, or white blood cells. By exploiting this mechanism, researchers have been able to powerfully suppress tumor formation in lab testing and in animal models.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has submitted additional patent applications, covering its Cobalamin-mediated oral drug delivery technology formulations of many global top-100 injectable drugs, as a result of the growing interest surrounding the company's proprietary oral delivery technology.
› Verified 3 days ago
Entity Name | Maine Medical Partners |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073527388 PECOS PAC ID: 9335043967 Enrollment ID: O20050401000844 |
News Archive
The research, reported in the New England Journal of Medicine, looked at the effect of a 2008 change that cut payments to hospitals for treating infections that patients received while hospitalized.
What factors have an influence in making us like sport in the physical education classes we receive in school? According to a new investigation, physical education teaching staff must develop the responsibility, encourage social interaction and avoid making comparisons between the pupils.
Wearing a surgical mask is unlikely to protect healthy people from the novel coronavirus that originated in China, and influenza likely poses a much greater threat to Americans, according to José Cordero, professor of epidemiology and biostatistics in the University of Georgia's College of Public Health.
Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, or white blood cells. By exploiting this mechanism, researchers have been able to powerfully suppress tumor formation in lab testing and in animal models.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has submitted additional patent applications, covering its Cobalamin-mediated oral drug delivery technology formulations of many global top-100 injectable drugs, as a result of the growing interest surrounding the company's proprietary oral delivery technology.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Nellie Delucia Wood, MD 22 Bramhall St, Portland, ME 04102-3175 Ph: () - | Dr Nellie Delucia Wood, MD 22 Bramhall St, Portland, ME 04102-3175 Ph: (207) 662-0111 |
News Archive
The research, reported in the New England Journal of Medicine, looked at the effect of a 2008 change that cut payments to hospitals for treating infections that patients received while hospitalized.
What factors have an influence in making us like sport in the physical education classes we receive in school? According to a new investigation, physical education teaching staff must develop the responsibility, encourage social interaction and avoid making comparisons between the pupils.
Wearing a surgical mask is unlikely to protect healthy people from the novel coronavirus that originated in China, and influenza likely poses a much greater threat to Americans, according to José Cordero, professor of epidemiology and biostatistics in the University of Georgia's College of Public Health.
Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, or white blood cells. By exploiting this mechanism, researchers have been able to powerfully suppress tumor formation in lab testing and in animal models.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has submitted additional patent applications, covering its Cobalamin-mediated oral drug delivery technology formulations of many global top-100 injectable drugs, as a result of the growing interest surrounding the company's proprietary oral delivery technology.
› Verified 3 days ago
Andrew J. Hsu, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 155 Fore River Pkwy, Portland, ME 04102 Phone: 207-535-1100 Fax: 207-879-8787 | |
David A Polisner, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 144 State St, Portland, ME 04101 Phone: 207-879-3000 | |
Dr. Elizabeth A Jacobs, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-0111 | |
Brian D Moore, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 144 State St, Portland, ME 04101 Phone: 207-879-3000 | |
Marc Stuart Hoffman, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 144 State St, Portland, ME 04101 Phone: 207-879-3265 | |
Janet D Mcculley, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-4618 | |
Saeeda Fatima, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St Rm 2227, Portland, ME 04102 Phone: 207-662-4618 |